Join a Clinical Study for Moderate to Severe Atopic Dermatitis in Northridge

About This Job

Northridge Clinical Trials is currently seeking individuals to participate in a research study focused on Moderate to Severe Atopic Dermatitis.

Do you live with Moderate to Severe Atopic Dermatitis? This condition often involves symptoms such as intense itching (pruritus), red or inflamed skin, dry and scaly patches, skin that has become thickened or leathery from scratching, oozing or crusting lesions, a pain or burning sensation in affected areas, sleep disruption due to itching, and recurring flare-ups that can sometimes lead to skin infection.

If this describes your experience, you may be eligible to join a clinical research study investigating a new potential treatment.

Contact Information

Phone: 818-350-7482
Apply Online: http://aaalist.org/xyz

Who May Be Eligible?

• Participants must be between 12 and 18 years old.
• Participant must be on a phototherapy or systemic treatment for psoriasis.
• Must have a diagnosis of Plaque Psoriasis.
• Female participants cannot be pregnant or breastfeeding.

Why Participants Choose Us

• Compensation for time and travel of up to $100 per clinic visit.
• Medical care and diagnostic testing are provided at no cost.
• Care from experienced and compassionate healthcare providers.
• No pressure to join; you may cancel your participation at any time.
• No insurance or specific documentation is required.

Additional Benefits

• Scheduling is convenient.
• Free laboratory work and health testing.
• Potential access to innovative, cutting-edge medications.
• A $100 referral bonus for referring friends or family members.

Other Studies We Are Conducting

• Moderate to Severe Plaque Psoriasis in Obese Patients
• Hidradenitis Suppurativa
• Acne Vaccine
• Type 2 Diabetes
• Atopic Dermatitis (Eczema)
• Future Studies

Visit Our Website to Learn More: http://www.northridgetrials.com

Please note that participation is entirely voluntary. The compensation provided varies depending on the specific study. © Northridge Clinical Trials